JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB306657

Human ELAVL3 knockout U-87 MG cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ELAVL3 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control available. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Next Generation Sequencing - Human ELAVL3 knockout U-87 MG cell line (AB306657)
  • NGS

Supplier Data

Next Generation Sequencing - Human ELAVL3 knockout U-87 MG cell line (AB306657)

103 bp deletion (allele 1) and 101 bp deletion (allele 2) after Asn23 of the WT protein

Key facts

Cell type

U-87 MG

Species or organism

Human

Tissue

Brain

Form

Liquid

form

Knockout validation

Next Generation Sequencing

Disease

Glioblastoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "NGS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab306657-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab278079 Human wild-type U-87 MG cell line", "number":"AB306657-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab306657 Human ELAVL3 knockout U-87 MG cell line", "number":"AB306657-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab306657-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab306657 Human ELAVL3 knockout U-87 MG cell line", "number":"AB306657-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ELAVL3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

EMEM + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HuC also known as ELAVL3 is a neuronal-specific RNA-binding protein part of the ELAV (embryonic lethal abnormal vision) family. It plays a mechanical role in the stabilization and transport of mRNA. HuC has a mass of approximately 36 kDa. It is expressed predominantly in neuronal tissues particularly within the brain where it engages in critical functions related to neural RNA metabolism.
Biological function summary

HuC significantly influences neuronal differentiation and development. It participates in controlling the stability and translation of mRNA transcripts in neurons. HuC often functions as part of larger RNA-protein complexes impacting the post-transcriptional modification of target RNAs. Through its ability to bind mRNA HuC promotes the expression of proteins essential for neuron function affecting how neurons develop and maintain their activity.

Pathways

HuC integrates into the post-transcriptional regulatory networks in neurons. It influences the MAPK signaling pathway which is important for cell proliferation and survival. Within these pathways HuC interacts with proteins such as HuD another member of the ELAV family to ensure proper mRNA processing and translational control. These interactions are vital for maintaining neuronal integrity and response to external stimuli.

HuC has connections to neurodegenerative conditions such as Alzheimer's disease and certain types of cancer involving neuronal tissue. The dysfunction or aberrant expression of HuC disrupts normal neuronal function contributing to disease progression. In these contexts HuC often interacts with the Tau protein in Alzheimer's suggesting its involvement in the pathological pathways leading to cognitive decline. Additionally dysregulated interaction with other RNA-binding proteins like HuR might exacerbate disease states by altering the stability of RNA transcripts.

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com